22 HIV AIDS Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting HIV AIDS Studies in New York

NCT06741631Recruiting

MyPEEPS LITE Trial

This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with ...

New York, NYNA3,200 participantsColumbia University

View Study Details

NCT05968573Recruiting

Persuasive Health Communication Intervention for HIV/HCV

A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the re...

New York, NYNA2,000 participantsUniversity of South Florida

View Study Details

NCT06741618Recruiting

MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information spe...

New York, NYNA500 participantsColumbia University

View Study Details

NCT06598397Recruiting

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of qui...

New York, NYPHASE4500 participantsNew York University

View Study Details

NCT06785376Recruiting

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of bot...

New York, NYNA480 participantsColumbia University

View Study Details

NCT03135886Recruiting

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and...

New York, NYNA418 participantsColumbia University

View Study Details

NCT06853314Recruiting

An Effectiveness Trial of the PrEP for WINGS Study

(Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adhere...

New York, NYNA307 participantsColumbia University

View Study Details

NCT05398185Recruiting

WiseApp for Spanish Speakers Living With HIV

This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (...

New York, NYNA248 participantsColumbia University

View Study Details

NCT04353778Recruiting

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

The study team's prior research has shown that dysfunction of a specific nerve, called the vagus nerve, is associated with small intestinal bacterial overgrowth (SIBO), and that SIBO is associated wit...

New York, NYPHASE1207 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06812494Recruiting

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

HVTN 206/HPTN 114 is a randomized, double blind, controlled, phase 2 clinical trial to evaluate the safety, tolerability, pharmacokinetics, and neutralization of VRC07-523LS, PGT121.414.LS, and PGDM14...

New York, NYPHASE2200 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05165745Recruiting

Stick2PrEP Cisgender Women and Trans Individuals

Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available...

New York, NYNA175 participantsColumbia University

View Study Details

NCT06890988Recruiting

Ending the Epidemic Interventions in the Dental Setting - UH3

The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting....

New York, NYNA128 participantsColumbia University

View Study Details

NCT04949464Recruiting

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking...

New York, NYNA100 participantsAIDS Malignancy Consortium

View Study Details

NCT07392372Recruiting

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

This study will test the safety and blood levels of the antibody BNT351 in people living without and with human immunodeficiency virus (HIV). This study will also test the anti-viral activity of BNT35...

New York, NYPHASE167 participantsBioNTech SE

View Study Details

NCT06796686Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

This is a partially randomized, open-label phase 1 study to evaluate the safety and immunogenicity of a priming regimen of 426c.Mod.Core-C4b adjuvanted with 3M-052 AF + Alum followed by boosts with Hx...

New York, NYPHASE142 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06665646Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged 18 to 60 years, who previously participat...

New York, NYPHASE140 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT07390474Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

This is a phase 1, multicenter, open-label, dose escalation, first-in-human (FIH) trial to evaluate the safety and immunogenicity of DV201P-RNA and DV202B1-RNA, immunogens designed to induce HIV-1 env...

New York, NYPHASE140 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06071767Recruiting

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

The purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored cons...

New York, NYPHASE136 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06868641Recruiting

The TAIL-PrEP Study

The goal of the TAIL-PrEP study is to understand how to support the safe discontinuation of injectable long-acting cabotegravir (cab-LA) and lenacapavir (LEN) while maximizing the public health impact...

New York, NYNA30 participantsColumbia University

View Study Details

NCT05985642Recruiting

Observational PIC Destination Cohort

This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The information collected in this study is als...

New York, NY30 participantsAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

View Study Details

NCT05077527Recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

This phase I trial evaluates the side effects and usefulness of axicabtagene clioleucel (a CAR-T therapy) and find out what effect, if any, it has on treating patients with HIV-associated aggressive B...

New York, NYPHASE120 participantsAIDS Malignancy Consortium

View Study Details

NCT05652088Recruiting

The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection

The objective of this study is to understand the effects of HIV cure strategies on the virus and immune cells that reside within the gastrointestinal tract. Subjects receiving therapies with the poten...

New York, NYNA10 participantsIcahn School of Medicine at Mount Sinai

View Study Details

About HIV AIDS Clinical Trials in New York

HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.

There are currently 22 hiv aids clinical trials recruiting participants in New York, NY. These studies are seeking a combined 8,778 participants. Research is being sponsored by Columbia University, University of South Florida, New York University and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

HIV AIDS Clinical Trials in New York — FAQ

Are there hiv aids clinical trials in New York?

Yes, there are 22 hiv aids clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What hiv aids treatments are being tested?

The 22 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.

Data updated July 19, 2026 from ClinicalTrials.gov